In Silico Medicine and Simulation
Academic Year 2026/2027 - Teacher: GIULIA RUSSOExpected Learning Outcomes
At the end of the course, students will be able to describe the fundamental principles of in silico medicine and computational simulation applied to biomedical systems; distinguish the main classes of predictive models, including ordinary and partial differential equation models, agent-based models, multiscale models, and hybrid approaches; explain the concepts of Virtual Patients, Digital Twins, and In Silico Trials; and illustrate the main stages of computational model development and evaluation, including conceptual modelling, parameterization, calibration, sensitivity analysis, uncertainty quantification, verification, validation, and credibility assessment. Students will also understand the role of computational models in biomedical research, drug and vaccine development, personalized medicine, and regulatory assessment.
Course Structure
The course includes lectures devoted to the theoretical and methodological principles of in silico medicine and computational modelling, complemented by guided exercises and the analysis and discussion of case studies, scientific articles, and representative applications in biomedical, clinical, industrial, and regulatory settings.
A central component of the course is the development, individually or in groups, of a project addressing a problem in the field of in silico medicine. Course activities will progressively guide students through problem identification, conceptual model definition, selection of the methodological approach, identification of the required data, and critical evaluation of verification, validation, and credibility assessment strategies.
Lectures primarily contribute to the development of knowledge and understanding, whereas practical exercises, case studies, and project activities are aimed at developing the ability to apply knowledge, make independent judgements, solve problems, learn autonomously, and communicate scientific information, in accordance with the intended learning outcomes.
Pursuant to Article 12 of the University Academic Regulations concerning University Educational Credits (CFU), within the standard workload of 25 total hours of student commitment corresponding to one credit, seven hours may be devoted to lectures or equivalent instructional activities, with the remaining hours reserved for individual study; alternatively, between twelve and fifteen hours may be devoted to classroom exercises or equivalent supervised activities, with the remaining hours reserved for individual study and elaboration.
If the course is delivered in blended or remote mode, appropriate adjustments may be made to the above, in order to ensure consistency with the syllabus.
Gli studenti e le studentesse possono utilizzare l’IA come strumento di supporto allo studio, nel rispetto della normativa vigente, ivi inclusa quella in materia di diritto d’autore e di utilizzo delle opere dell’ingegno come descritto nel punto 5.1 delle linee guida (https://www.unict.it/it/ateneo/cidia-centro-l%E2%80%99informatica-la-digitalizzazione-e-l%E2%80%99intelligenza-artificiale).
Required Prerequisites
Attendance of Lessons
Detailed Course Content
1. Introduction to In Silico Medicine
Evolution of computational medicine.
Definition and principles of in silico medicine.
The role of simulation in biomedical research, drug development, and personalized medicine.
Digital Health, Precision Medicine, and Digital Twins.
2. Fundamentals of Computational Modeling
Conceptual and computational models.
Taxonomy of predictive models.
Deterministic, stochastic, mechanistic, and data-driven models.
Multiscale modelling.
3. Mathematical and Computational Modelling Methods
Ordinary Differential Equations (ODEs).
Partial Differential Equations (PDEs).
Agent-Based Modelling (ABM).
Hybrid models and integration with Artificial Intelligence techniques.
4. Model Development and Evaluation
Definition of the biomedical problem.
Conceptual modelling.
Model parameterization and calibration.
Sensitivity analysis.
Uncertainty quantification.
Verification and validation.
Model credibility assessment and Context of Use.
5. In Silico Medicine and Digital Twins
Virtual Patients.
Digital Twins.
Disease progression simulation.
Personalized medicine.
6. In Silico Trials (8 hours)
In silico clinical trials.
Virtual populations.
Simulation of therapeutic response.
Applications to drug and vaccine development.
7. Applications of In Silico Medicine
Oncology.
Immunology.
Infectious diseases.
Neurological and autoimmune diseases.
Clinical decision support.
8. Regulatory Aspects and Future Perspectives
Assessment of model reliability.
National and international regulatory landscape.
The role of in silico medicine in the development of health technologies.
Challenges and future perspectives.
Textbook Information
1. Teaching materials, slides, and lecture notes provided by the teacher and made available through the Studium platform.
2. Scientific articles and additional reading materials selected by the teacher and made available during the course.
Course Planning
| Subjects | Text References | |
|---|---|---|
| 1 | 1. Introduction to In Silico Medicine | |
| 2 | 2. Fundamentals of Computational Modelling | |
| 3 | 3. Mathematical and Computational Modelling Methods | |
| 4 | 4. Model Development, Verification, Validation and Credibility Assessment | |
| 5 | 5. Virtual Patients and Digital Twins | |
| 6 | 6. In Silico Trials | |
| 7 | 7. Applications of In Silico Medicine | |
| 8 | 8. Regulatory Aspects and Future Perspectives |
Learning Assessment
Learning Assessment Procedures
Learning assessment consists of the development and presentation of an individual or group project addressing a problem in the field of in silico medicine.
The project may consist of the design of a computational model, the development of a conceptual model, the critical analysis of an existing model, the analysis of a case study from the scientific literature, or the critical appraisal of a particularly relevant scientific article.
Students will be expected to demonstrate their ability to correctly identify and describe the biomedical problem, select and justify the most appropriate modelling approach, identify the required data and information, correctly apply the methodological principles covered during the course, and critically analyse assumptions, results, limitations, and sources of uncertainty. Students will also be expected to discuss appropriate verification, validation, and credibility assessment strategies in relation to the model Context of Use and to consider its potential applications in scientific, clinical, industrial, or regulatory settings.
The project will be presented and discussed in order to assess students’ understanding of the theoretical and methodological principles of the course, independent judgement, ability to connect different topics covered in the syllabus, ability to justify methodological choices, and appropriate use of scientific and technical terminology.
For group projects, the assessment will also take into account each student’s individual contribution and ability to discuss the project.
The final grade will be based on an overall assessment of:
- knowledge and understanding of the principles of in silico medicine and computational modelling;
- ability to apply the acquired knowledge to the problem addressed;
- appropriateness and scientific rigour of methodological choices;
- critical thinking and independent judgement;
- scientific quality and internal coherence of the project;
- ability to appropriately use and interpret scientific literature and other relevant sources;
- clarity of presentation and appropriate use of scientific and technical terminology.
The final grade will be assigned according to the following general criteria:
Fail: the project presents substantial deficiencies in the understanding of the problem or in the application of methodological principles; the student demonstrates insufficient or fragmentary knowledge and is unable to adequately justify the choices made.
18–21: the project correctly addresses the essential aspects of the problem, although with limited depth and critical analysis; knowledge and ability to apply the acquired concepts are sufficient, and the presentation is generally understandable.
22–25: the project demonstrates satisfactory knowledge of the course contents and an adequate ability to apply and connect concepts; methodological choices are generally appropriate and justified, and the presentation uses appropriate scientific terminology.
26–28: the project demonstrates good knowledge and understanding of the discipline, methodological appropriateness, the ability to integrate different concepts, and good independence in critical analysis; the presentation is clear and rigorous and makes appropriate use of scientific terminology.
29–30 with honours: the project demonstrates comprehensive and in-depth knowledge, excellent ability to apply and integrate concepts, full independent judgement, and particularly rigorous critical analysis of methodological choices, results, limitations, and implications; the presentation and discussion demonstrate scientific maturity and excellent communication skills.
In the case of a group project, the assessment will also take into account each student’s individual contribution and ability to discuss the project.
Learning assessment may also be carried out on-line, should the conditions require it.
To ensure equal opportunities and in compliance with current laws, interested students may request a personal interview in order to plan any compensatory and/or dispensatory measures based on educational objectives and specific needs. Students may also contact the CInAP referring teacher within their Department.
Examples of frequently asked questions and / or exercises
1. Comparatively analyse mechanistic, data-driven, and hybrid models applicable to a specific biomedical problem, discussing their rationale, advantages, limitations, and potential fields of application.
2. Starting from the description of a biomedical problem, such as an infectious, oncological, neurological, or autoimmune disease, design an appropriate modelling strategy by identifying the computational paradigm, conceptual model, required data, and verification and validation strategies.
3. Design the development and evaluation lifecycle of a computational model, from problem definition and Context of Use to conceptual modelling, parameterization, calibration, sensitivity analysis, uncertainty quantification, verification, validation, and credibility assessment.
4. Analyse an application of a Digital Twin in personalized medicine, discussing its structure, data requirements, updating strategy, potential applications, limitations, and future perspectives.
5. Critically analyse a scientific article in the field of in silico medicine, discussing the biomedical problem addressed, conceptual model, modelling paradigm, Context of Use, Verification, Validation and Credibility Assessment strategies, main findings, and potential scientific, clinical, or regulatory impact.